Data was presented in Athens supporting a future U.S. NDA submission to the FDA.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Athens →

  capital and largest city of Greece

  • Cities announce hosting duties for the 2027 Water Polo World Cup and the qualifiers for the LA 2028 Olympics.Mon 17:19
  • Various travel experiences are offered across Europe, including cruises from Athens and Copenhagen, and Ferrari driving near Bologna.Mon 13:03

Related events

• The FDA requested additional clinical data from Unicycive Therapeutics.Jun 29
• A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.Sep 2
• A clinical study led by Dr. Swee Lay Thein is underway at the National Institutes of Health and is subject to oversight by the Food and Drug Administration.Aug 19
• A product was launched in the U.S. market following FDA involvement.Sep 8
• The FDA operates under US law to evaluate international clinical data.Fri 03:42